Majmudar & Partners acts as Indian legal counsel to Cryoport, INC. on its acquisition of the Cryopdp Group for EUR49 Million

by | Aug 26, 2020

Cryoport, Inc. (NASDAQ: CYRX) has entered into an agreement to acquire CRYOPDP, a leading global provider of innovative temperature-controlled logistics solutions to the clinical research, pharmaceutical and cell and gene therapy markets, headquartered in Paris, France, with 22 global facilities in 12 countries (including India). The purchase price is approximately EUR49 million.

The acquisition will provide significant complementary synergies from a geographic as well as service and product support standpoint. As a unified platform, Cryoport and CRYOPDP will be able to provide market leading support to the most complex and high value life sciences product supply chains across the full spectrum of controlled temperature ranges and create significant global cross-selling opportunities.

The Majmudar & Partners’ team was led by Managing Partner, Akil Hirani, with able support from partner, Amrit Mehta, tax counsel, Ravi S. Raghavan and associates, Sinjini Majumdar and Dhruv Somayajula.

More News

Benchmark Litigation Rankings 2022

We are pleased to announce that Majmudar & Partners has been recognised by Benchmark Litigation Asia-Pacific 2022. Neerav Merchant, Partner and Head of Disputes, has been named as a Litigation Star for the practice area of Commercial and Transactions. The firm has...

read more